Affordable Access

Access to the full text

Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer

Authors
  • Mace, Thomas1
  • Shakya, Reena2
  • Pitarresi, Jason2
  • Loftus, Shannon2
  • Swanson, Benjamin2
  • Young, Gregory3
  • Zhong, Xioling4
  • Zimmers, Teresa4
  • Ostrowski, Michael2
  • Ludwig, Thomas2
  • Bloomston, Mark2
  • Bekaii-Saab, Tanios2
  • Lesinski, Gregory1
  • 1 The Ohio State University, Department of Internal Medicine, James Comprehensive Cancer Center, Columbus, OH, USA , Columbus (United States)
  • 2 The Ohio State University, Columbus, OH, USA , Columbus (United States)
  • 3 The Ohio State University, Center for Biostatistics, Columbus, OH, USA , Columbus (United States)
  • 4 Indiana University Simon Cancer Center, Indianapolis, IN, USA , Indianapolis (United States)
Type
Published Article
Journal
Journal for ImmunoTherapy of Cancer
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Nov 04, 2015
Volume
3
Issue
Suppl 2
Identifiers
DOI: 10.1186/2051-1426-3-S2-P366
Source
Springer Nature
Keywords
License
Green
Report this publication

Statistics

Seen <100 times